Clinical Trials List
2019-07-15 - 2022-12-31
Phase III
Recruiting7
ICD-10C90.00
Multiple myeloma not having achieved remission
ICD-10C90
Multiple myeloma and malignant plasma cell neoplasms
-
Trial Applicant
TAIWAN PSI HEALTH DEVELOPMENT COMPANY LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Liang-Tsai Hsiao Division of Hematology & Oncology
- Tzeon-jye Chiou Division of Hematology & Oncology
- Jyh-Pyng Gau Division of Hematology & Oncology
- Hao-Yuan Wang Division of Hematology & Oncology
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Sheng-Fung Lin Division of Hematology & Oncology
- 蘇裕傑 Division of Hematology & Oncology
- 張肇松 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Shang-Ju Wu Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- RUOH-FANG YEN Division of Hematology & Oncology
- Shang-Yi Huang Division of Hematology & Oncology
- Chieh-Lung Cheng Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- 林耘曲 Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- 徐思淳 Division of Hematology & Oncology
- BANG-BIN CHEN Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- Jih-Luh Tang Division of Hematology & Oncology
- NAI-HSIN CHI Division of Hematology & Oncology
- - - 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
- Yi-Chang Liu Division of Hematology & Oncology
- Shih-Feng Cho Division of Hematology & Oncology
- 唐世豪 Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
- Hui-Ching Wang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Che-Hung Lin Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Ya-Ting Hsu Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Sin-Syue Li Division of Hematology & Oncology
- Ya-Ping Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Audit
None
Co-Principal Investigator
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
22 participants
-
Global
450 participants
